A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
Conditions: Alpha 1-Antitrypsin Deficiency; Emphysema; COPD Interventions: Drug: Placebo Oral Tablet; Drug: Alvelestat oral tablet - dose 1; Drug: Alvelestat oral tablet - dose 2 Sponsors: Mereo BioPharma; Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials